Stock OMGA OMEGA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Omega Therapeutics, Inc.

Equities

OMGA

US68217N1054

Real-time Estimate Cboe BZX
Other stock markets
 03:16:40 2024-06-07 pm EDT 		5-day change 1st Jan Change
2 USD -1.48% Intraday chart for Omega Therapeutics, Inc. +1.01% -33.55%
May. 30 Omega Therapeutics, Inc. Announces Termination of Yan Moore as Chief Medical Officer CI
May. 29 Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Piper Sandler Trims Price Target on Omega Therapeutics to $9 From $10, Maintains Overweight Rating
MT
Chardan Cuts Price Target on Omega Therapeutics to $7 From $12, Keeps Buy Rating
MT
HC Wainwright Adjusts Omega Therapeutics' Price Target to $12 From $11, Maintains Buy Rating
MT
Wedbush Lowers Omega Therapeutics' PT to $12 From $19, Adjusts Financing Assumptions; Keeps Outperform Rating
MT
Wedbush Lowers Omega Therapeutics' Price Target to $19 From $23, Adjusts Financing Assumptions; Keeps Outperform Rating
MT
JonesTrading Initiates Omega Therapeutics at Buy With $11 Price Target
MT
Piper Sandler Adjusts Omega Therapeutics' Price Target to $10 From $8, Keep Overweight Rating
MT
Wedbush Cuts Omega Therapeutics's Price Target to $23 From $25, Maintains Outperform Rating
MT
HC Wainwright Initiates Omega Therapeutics With Buy Rating, Sets Price Target at $11
MT
Wedbush Lifts Omega Therapeutics' Price Target to $25 From $24, Keeps Outperform Rating
MT
Chardan Starts Omega Therapeutics at Buy With $12 Price Target
MT
Goldman Sachs Adjusts Price Target for Omega Therapeutics to $4 From $7, Retains Neutral Rating
MT
Piper Sandler Lowers Omega Therapeutics' Price Target to $7 From $30, Maintains Overweight Rating
MT
Wedbush Adjusts Price Target on Omega Therapeutics to $24 From $30, Keeps Outperform Rating
MT
Wedbush Adjusts Omega Therapeutics' Price Target to $30 From $36, Keeps Outperform Rating
MT
OMEGA THERAPEUTICS : Jefferies Starts Omega Therapeutics at Buy With $30 Price Target
MT
OMEGA THERAPEUTICS : Goldman Sachs Starts Omega Therapeutics at Neutral With $22 Price Target
MT
OMEGA THERAPEUTICS : Piper Sandler Starts Omega Therapeutics at Overweight With $30 Price Target
MT
OMEGA THERAPEUTICS : Wedbush Starts Omega Therapeutics at Outperform With $36 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OMGA Stock
  4. News Omega Therapeutics, Inc.
  5. Analyst Reco.